![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEibjPSt_x9XxVe0cxaibUkFsfPKbESiC98X6xiktHVeonk4uUwfM_NBctGAuFDC-a6msUgbSjYBilmhmEV8WRIMKKF4fBhwpRVkLI1CVsjNcK6b5H8YDeMfTBaFZJ2zcZV648GQqQ/s200/attack.jpg)
Guess what? The Pharmaceutical Care Management Association (PCMA), which represents pharmacy benefit managers (PBMs), just released a blistering report that adds fuel to the fire. The title unambiguously sums up the report’s tone: How Copay Coupons Could Raise Prescription Drug Costs By $32 Billion Over the Next Decade.
My manufacturer clients recognize that it's becoming a payer-driven world, which is why the PBM/pharmaceutical manufacturer relationships can often be described as: The best of frenemies!
Below are four questions to help you think about the future of copay cards for manufacturers, PBMs, and pharmacies.